obesity
OBESITY
Obesity is having an excessive amount of body fat that may impair health.
The primary cause is an energy imbalance between calories consumed and expended.
Treatment goals include addressing the principal cause of weight gain and focusing management on both weight loss and patient-centered health outcomes.
A multidisciplinary approach, that is a combination of dietary change, physical activity and behavioral modification, is recommended.

Surgical Intervention

Bariatric Surgery

  • Most effective method to reduce and maintain weight in severely obese patients
  • Associated with average weight losses of between 16-35% of up to 8 years depending on type of surgical procedure
    • Laparoscopic technique is the first treatment of choice
  • Based on long-term data, surgery has been shown to reduce overall mortality over a 15-year period compared to conservative medical treatment
  • May fail in up to 35% of patients after 5 years in patients with BMI >35
  • According to the 2016 American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) guidelines, it is indicated in patients with BMI ≥40 or BMI 35-39.9 with comorbidities in whom weight loss through surgery is expected to improve the disorder (eg diabetes mellitus and other metabolic disorders, cardiovascular disease, severe joint disease, and obesity-related severe psychological disorders)
  • Should be considered in patients with BMI 30-34.9 and poorly controlled T2DM despite optimal medical treatment  
  • May be considered in patients with BMI 30-34.9 who have not achieved significant weight loss despite optimal medical and behavioral treatment
  • The International Federation for the Surgery of Obesity and Metabolic Disorders - Asia Pacific Chapter (IFSO-APC) consensus statements in 2011 recommend bariatric surgery in the following Asian patients with:
    • BMI ≥35 with or without comorbidities
    • BMI ≥30 inadequately controlled by lifestyle changes or medical therapy for the treatment of T2DM or metabolic syndrome
    • BMI ≥27.5 as non-primary treatment alternative for inadequately controlled T2DM or metabolic syndrome
  • Contraindications:
    • Current alcohol abuse
    • Unstable psychological conditions
    • Esophageal dysmotility, inflammatory bowel disease, chronic pancreatitis, bile duct pathology
    • Portal hypertension, active malignancy
    • Regular use of NSAIDs or corticosteroids
    • History of gastric cancer
    • Vegetarians
  • Medical follow-up at 1, 3, 6 and 12 months then annually is advised
  • Complications may include dumping syndrome, hypoglycemia, malnutrition, regain of weight, or revisional surgery
  • Long-term mineral and multivitamin supplementation is recommended post-surgery
  • Restrictive Procedure
    • Limits intake of food by creating small gastric pouch causing feeling of fullness
    • Estimated weight loss of 30% in 1 year
    • Eg vertical sleeve gastrectomy, laparoscopic adjustable gastric band, intragastric balloon (IGB)
  • Malabsorptive Procedure
    • Limits absorption of macronutrients
    • Eg biliopancreatic diversion, duodenal switch, gastric bypass
    • Gastric bypass is the gold standard in bariatric surgical operation as it produced massive weight loss in obese patients
      • Roux-en-Y gastric bypass combines both restrictive and malabsorptive techniques
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Regular practice of yoga postures confers benefits for glucose control, oxidative stress, inflammatory response, and sleep quality in patients with type 2 diabetes, a study has found.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
6 days ago
Women with central adiposity, regardless of menopausal status, are at risk of developing breast cancer, according to a study.